Literature DB >> 24488205

Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment.

Tarsila Barros Moraes1, Giovana Reche Dalazen, Carlos Eduardo Jacques, Raylane Silva de Freitas, Andrea Pereira Rosa, Carlos Severo Dutra-Filho.   

Abstract

Phenylketonuria (PKU) is a disorder caused by a deficiency in phenylalanine hydroxylase activity, which converts phenylalanine (Phe) to tyrosine, leading to hyperphenylalaninemia (HPA) with accumulation of Phe in tissues of patients. The neuropathophysiology mechanism of disease remains unknown. However, recently the involvement of oxidative stress with decreased glutathione levels in PKU has been reported. Intracellular glutathione (GSH) levels may be maintained by the antioxidant action of lipoic acid (LA). The aim of this study was to evaluate the activity of the enzymes involved in the metabolism and function of GSH, such as glutathione peroxidase (GSH-Px), glucose-6-phosphate dehydrogenase (G6PD), glutathione reductase (GR), glutamate-cysteine ligase (GCL), glutathione-S-transferase (GST) and GSH content in brain and liver of young rats subjected to a chemically induced model of HPA and the effect of LA for a week. In brain, the administration of Phe reduced the activity of the GSH-Px, GR and G6PD and LA prevented these effects totally or partially. GCL activity was increased by HPA and was not affect by LA antioxidant treatment. GST activity did not differ between groups. GSH content was increased by LA and decreased by HPA treatment in brain samples. Considering the liver, all parameters analyzed were increased in studied HPA animals and LA was able to hinder some effects except for the GCL, GST enzymes and GSH content. These results suggested that HPA model alter the metabolism of GSH in rat brain and liver, which may have an important role in the maintenance of GSH function in PKU although liver is not a directly affected organ in this disease. So, an antioxidant therapy with LA may be useful in the treatment of oxidative stress in HPA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488205     DOI: 10.1007/s11011-014-9491-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  53 in total

1.  Regional enzyme development in rat brain. Enzymes associated with glucose utilization.

Authors:  S F Leong; J B Clark
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

2.  Experimental hyperphenylalaninemia provokes oxidative stress in rat brain.

Authors:  Martine E Kienzle Hagen; Carolina D Pederzolli; Angela M Sgaravatti; Raquel Bridi; Moacir Wajner; Clóvis M D Wannmacher; Angela T S Wyse; Carlos S Dutra-Filho
Journal:  Biochim Biophys Acta       Date:  2002-04-24

3.  Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria.

Authors:  R Artuch; C Colomé; M A Vilaseca; C Sierra; F J Cambra; N Lambruschini; J Campistol
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

4.  Rat liver glutathione: possible role as a reservoir of cysteine.

Authors:  N Tateishi; T Higashi; A Naruse; K Nakashima; H Shiozaki
Journal:  J Nutr       Date:  1977-01       Impact factor: 4.798

Review 5.  The role of amino acid transporters in GSH synthesis in the blood-brain barrier and central nervous system.

Authors:  Cesar Valdovinos-Flores; María E Gonsebatt
Journal:  Neurochem Int       Date:  2012-05-24       Impact factor: 3.921

6.  Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases.

Authors:  Rute R da Fonseca; Warren E Johnson; Stephen J O'Brien; Vítor Vasconcelos; Agostinho Antunes
Journal:  BMC Evol Biol       Date:  2010-09-15       Impact factor: 3.260

Review 7.  Neurological aspects of adult phenylketonuria.

Authors:  J Pietz
Journal:  Curr Opin Neurol       Date:  1998-12       Impact factor: 5.710

8.  Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Amanda T Barden; Giovana B Biancini; Paula R Vargas; Carolina F de Souza; Cristina Netto; Moacir Wajner; Carmen R Vargas
Journal:  Int J Dev Neurosci       Date:  2009-01-20       Impact factor: 2.457

Review 9.  Regulation of glutathione synthesis.

Authors:  Shelly C Lu
Journal:  Mol Aspects Med       Date:  2008-06-14

Review 10.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

View more
  9 in total

1.  Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.

Authors:  Fatemeh Keshavarzi; Mohsen Rastegar; Mahmood Vessal; Gholamreza Rafiei Dehbidi; Marjan Khorsand; Amir Hossein Ganjkarimi; Mohammad Ali Takhshid
Journal:  Metab Brain Dis       Date:  2017-12-21       Impact factor: 3.584

Review 2.  Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.

Authors:  Angela T S Wyse; Tiago M Dos Santos; Bianca Seminotti; Guilhian Leipnitz
Journal:  Mol Neurobiol       Date:  2021-02-06       Impact factor: 5.590

3.  Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Authors:  Charlotte Veyrat-Durebex; Christelle Debeissat; Hélène Blasco; Franck Patin; Hélène Henique; Patrick Emond; Catherine Antar; Valérie Gissot; Olivier Herault; François Maillot
Journal:  JIMD Rep       Date:  2017-03-15

Review 4.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

5.  Voluntary Exercise Prevents Oxidative Stress in the Brain of Phenylketonuria Mice.

Authors:  Priscila Nicolao Mazzola; Vibeke Bruinenberg; Karen Anjema; Danique van Vliet; Carlos Severo Dutra-Filho; Francjan J van Spronsen; Eddy A van der Zee
Journal:  JIMD Rep       Date:  2015-10-07

6.  Creatine nanoliposome reverts the HPA-induced damage in complex II-III activity of the rats' cerebral cortex.

Authors:  Nathana Jamille Mezzomo; Diego Becker Borin; Francine Ianiski; Barbara Dotto Fontana; Itiane Diehl de Franceschi; Juliane Bolzan; Renata Garcez; Mateus Grings; Belisa Parmeggiani; Liana da Silva Fernandes; Rodrigo de Almeida Vaucher; Guilhian Leipnitz; Clovis Milton Duval Wannmacher; Virginia Cielo Rech
Journal:  Mol Biol Rep       Date:  2019-08-13       Impact factor: 2.316

7.  Rapid noninvasive screening of cerebral ischemia and cerebral infarction based on tear Raman spectroscopy combined with multiple machine learning algorithms.

Authors:  Yangyang Fan; Xiaodong Xie; Cheng Chen; Bo Yang; Wei Wu; Feilong Yue; Xiaoyi Lv; Chen Chen
Journal:  Lasers Med Sci       Date:  2021-05-10       Impact factor: 3.161

8.  Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury.

Authors:  Yahya M Naguib; Rania M Azmy; Rehab M Samaka; Mohamed F Salem
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

Review 9.  Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients.

Authors:  Máximo Vento; Consuelo Cháfer-Pericás; Dolores Rausell; Ana García-Blanco; Patricia Correcher; Isidro Vitoria
Journal:  Pediatr Res       Date:  2018-10-17       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.